VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $19,528,000 | +6.2% | 1,224,332 | +10.8% | 0.00% | 0.0% |
Q3 2016 | $18,392,000 | +48.2% | 1,105,311 | -0.3% | 0.00% | +50.0% |
Q2 2016 | $12,408,000 | +35.8% | 1,108,854 | +1.4% | 0.00% | 0.0% |
Q1 2016 | $9,140,000 | -8.9% | 1,093,279 | +1.4% | 0.00% | 0.0% |
Q4 2015 | $10,037,000 | -15.8% | 1,078,042 | +2.1% | 0.00% | 0.0% |
Q3 2015 | $11,916,000 | -16.6% | 1,056,365 | -6.2% | 0.00% | 0.0% |
Q2 2015 | $14,292,000 | +38.3% | 1,126,256 | +1.4% | 0.00% | 0.0% |
Q1 2015 | $10,334,000 | -36.6% | 1,111,149 | -2.3% | 0.00% | -33.3% |
Q4 2014 | $16,290,000 | +48.8% | 1,137,570 | +7.9% | 0.00% | +50.0% |
Q3 2014 | $10,947,000 | -36.6% | 1,054,641 | -1.2% | 0.00% | -33.3% |
Q2 2014 | $17,274,000 | -1.6% | 1,067,598 | -1.1% | 0.00% | 0.0% |
Q1 2014 | $17,548,000 | +35.3% | 1,079,870 | +3.3% | 0.00% | +50.0% |
Q4 2013 | $12,968,000 | +18.0% | 1,044,986 | +4.1% | 0.00% | 0.0% |
Q3 2013 | $10,989,000 | +49.1% | 1,003,542 | +10.0% | 0.00% | +100.0% |
Q2 2013 | $7,372,000 | – | 912,374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
EMC Capital Management | 16,185 | $176,000 | 0.15% |